Monoclonal antibodies are a great example of recent progress to fight COVID-19, and all other infectious diseases. We stopped by at Healthline to catch up on progress, and learned intriguing details we did not know before. This form of counter attack reminds us of spy games in the movies. And how the good agent gets behind the enemy and attacks from behind.
Monoclonal Antibodies Team With Our Immune Systems
Monoclonal antibodies imitate our own bodily immune systems, and team with them to repel a COVID-19 invasion. They have done so successfully since their emergency-use approval in November 2020. And proved their effectiveness in helping reduce hospitalization, and emergency room visits too.
An antibody is a protein our immune system produces as a response to a particular infection. Such proteins are invaluable allies in our body’s fight to repel the invaders. The monoclonal antibodies in COVID-19 medication fulfill a similar function. However, they do not prevent the infection. That’s what vaccines do!
How Those Antibodies Stop an Infection Spreading
Monoclonal antibodies enter our bodies through medication, find COVID-19 viruses, and latch on to their spike protein. This prevents those invaders entering our healthy cells, and slows the rate of infection. We can then treat our symptoms more effectively, and recover sooner from the side effects.
We should hasten to mention this is a new form of medication that emerged as a result of the pandemic. Therefore, our scientists will have to wait a while longer before they know how long it lasts. However, we do know that if we have severe COVID it should be able to help limit the infection.
Who Are the Leading Candidates for This Treatment?
We are not qualified to give specific medical opinions. You should always ask a health practitioner before embarking on a new treatment you did not take before. However, Healthline does suggest people at high risk should consider the medication, in the event they test positive for COVID-19.
Breaking News
Sleeping Better in the Post-Pandemic Era
Adverse COVID Vaccine Reactions Minimal
